Salvage chemotherapy for patients with germ cell tumors. The memorial sloan‐kettering cancer center experience (1979–1989)
暂无分享,去创建一个
N. Geller | R. Motzer | P. Russo | W. Fair | G. Bosl | J. Sheinfeld | H. Herr | M. Morse | P. Sogani | C. Tan
[1] E. Dmitrovsky,et al. The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors , 1990, Cancer.
[2] N. Geller,et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] N. Geller,et al. Carboplatin, etoposide, and bleomycin for patients with poor‐risk germ cell tumors , 1990, Cancer.
[4] G. Tricot,et al. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] L. Einhorn,et al. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. , 1988, Annals of internal medicine.
[6] N. Geller,et al. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] N. Geller,et al. Identification and management of poor risk patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. , 1988, Seminars in oncology.
[8] C. Théodore,et al. Salvage chemotherapy in refractory germ cell tumors with etoposide (vp‐16) plus ifosfamide plus high‐dose cisplatin. A vihp regimen , 1988, Cancer.
[9] N. Geller,et al. Advanced Seminoma: The Role of Chemotherapy and Adjunctive Surgery , 1988, Annals of Internal Medicine.
[10] L. Einhorn,et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. , 1987, The New England journal of medicine.
[11] N. Geller,et al. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Motzer,et al. Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin. , 1987, Cancer treatment reports.
[13] N. Geller,et al. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Hainsworth,et al. Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] G. Bosl,et al. Phase II trial of mitoguazone in patients with refractory germ cell tumors. , 1985, Cancer treatment reports.
[16] G. Bosl,et al. Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. , 1985, The American journal of medicine.
[17] N. Geller,et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. , 1983, Cancer research.
[18] L. Einhorn,et al. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction , 1981, Cancer.
[19] M. Bains,et al. Combined chemotherapy and surgery in treatment of advanced germ‐cell tumors , 1981, Cancer.
[20] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[21] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .